Target
D(3) dopamine receptor
Ligand
BDBM476922
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
0.075±n/a nM
Citation
 Tobinaga, HMasuda, KInagaki, MYonehara, MMasuda, M Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect US Patent  US10870660 Publication Date 12/22/2020 
Target
Name:
D(3) dopamine receptor
Synonyms:
DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3
Type:
n/a
Mol. Mass.:
44243.43
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
400
Sequence:
MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM476922
Synonyms:
US10870660, Compound II-078 | US11345716, Compound II-078
Type:
Small organic molecule
Emp. Form.:
C25H33F3N4O4
Mol. Mass.:
510.5491
SMILES:
Cc1cc(OCC(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OCC(F)(F)F)nc4CC3)CC2)no1 |r,wU:12.12,wD:9.8,(14.16,2.98,;12.62,2.98,;11.59,1.83,;10.18,2.46,;8.85,1.69,;7.52,2.46,;6.18,1.69,;6.18,.15,;4.85,2.46,;3.51,1.69,;2.18,2.46,;.85,1.69,;.85,.15,;-.49,-.62,;-1.82,.15,;-3.15,-.62,;-3.04,-2.16,;-4.17,-3.21,;-5.69,-2.98,;-6.46,-4.31,;-8,-4.31,;-8.77,-2.98,;-10.31,-2.98,;-11.08,-1.64,;-12.62,-1.64,;-13.39,-.31,;-13.39,-2.98,;-14.16,-1.64,;-8,-1.64,;-6.46,-1.64,;-5.9,-.21,;-4.43,.25,;2.18,-.62,;3.51,.15,;10.34,3.99,;11.85,4.31,)|
Structure:
Search PDB for entries with ligand similarity: